BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Treatment
471 results:

  • 1. Temporal trends and regional variability in BRAF and KRAS genetic testing in Denmark (2010-2022): Implications for precision medicine.
    Frost MG; Jensen KJ; Jimenez-Solem E; Qvortrup C; Kuhlmann TP; Andersen JL; Høgdall E; Petersen TS
    Genes Chromosomes Cancer; 2024 Apr; 63(4):e23236. PubMed ID: 38656617
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Mycosis fungoides with large cell transformation (CD30+) and B-cell chronic lymphocytic leukemia.
    Petković M; Ilić I; Jurakić Tončić R; Radman-Livaja I; Čeović R
    Acta Dermatovenerol Croat; 2023 Dec; 31(4):223-224. PubMed ID: 38651850
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Functional genomics identifies N-acetyllactosamine extension of complex N-glycans as a mechanism to evade lysis by natural killer cells.
    Zhuang X; Woods J; Ji Y; Scheich S; Mo F; Rajagopalan S; Coulibaly ZA; Voss M; Urlaub H; Staudt LM; Pan KT; Long EO
    Cell Rep; 2024 Apr; 43(4):114105. PubMed ID: 38619967
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A combined subsegmentectomy of right S9 + 10b with single direction thoracoscopic surgery.
    Shen C; Liu C
    J Cardiothorac Surg; 2024 Apr; 19(1):206. PubMed ID: 38614999
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Suppression of NSCLC progression via the co-administration of Danusertib, an AURK inhibitor, and KRIBB11, an HSF1 inhibitor.
    Zhang X; Lei Y; Chen X; He J; Liu Z; Zhu W; Xu Y; Jin X
    Biochem Pharmacol; 2024 May; 223():116155. PubMed ID: 38521474
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Polyphyllin I enhances tumor necrosis factor-related apoptosis-inducing ligand-induced inhibition of human osteosarcoma cell growth downregulating the Wnt/β-catenin pathway.
    Junli C; Fulai Z; Xingyuan S; Xiaoping MA; Peng Z; Chujie Z; Binhao S; Wenchao GU; Yongjun W; Yanping Y
    J Tradit Chin Med; 2024 Apr; 44(2):251-259. PubMed ID: 38504531
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Naringenin nanoparticles targeting cyclin B1 suppress the progression of rheumatoid arthritis-associated lung cancer by inhibiting fibroblast-to-myofibroblast transition.
    Wang X; Zhang X; Liu Z; Zhao N; Li X; Su P; Zheng G; Zhang X; Wang H; Zhang Y
    Int J Biochem Cell Biol; 2024 Apr; 169():106557. PubMed ID: 38460905
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Carnosic Acid against lung cancer: Induction of Autophagy and Activation of Sestrin-2/LKB1/AMPK Signalling.
    O'Neill EJ; Sze NSK; MacPherson REK; Tsiani E
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396629
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Tumor microenvironment(TME) and single-source dual-energy CT(ssDECT) on assessment of inconformity between RECIST1.1 and pathological remission in neoadjuvant immunotherapy of NSCLC.
    Sun C; Ma X; Meng F; Chen X; Wang X; Sun W; Xu Y; He H; Zhang H; Ma K
    Neoplasia; 2024 Apr; 50():100977. PubMed ID: 38354688
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. RNA-binding protein RPS7 promotes hepatocellular carcinoma progression via LOXL2-dependent activation of ITGB1/FAK/SRC signaling.
    Zhou YJ; Yang ML; He X; Gu HY; Ren JH; Cheng ST; Fu Z; Zhang ZZ; Chen J
    J Exp Clin Cancer Res; 2024 Feb; 43(1):45. PubMed ID: 38326908
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Surgical Resection and Adjuvant Chemotherapy for Early Multiple Peritoneal Recurrence after Rejection of Hepatocellular Carcinoma-A Case Report].
    Yamaguchi S; Onoe T; Fujii T; Shibata Y; Tazuma S; Akimoto S; Sada H; Shimada N; Tazawa H; Suzuki T; Sudo T; Shimizu Y; Tashiro H
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1450-1452. PubMed ID: 38303304
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [The Usefulness of RFA as a Conversion Therapy after Molecular Targeted Therapy for Advanced Hepatocellular Carcinoma-A Case of Long-Term Survival with Multidisciplinary treatment].
    Matsumoto T; Hayashi H; Adachi Y; Kanemitsu K; Tajiri T; Yumoto S; Ogawa D; Shiraishi Y; Takematsu T; Tsukamoto M; Miyata T; Nakagawa S; Mima K; Nitta H; Baba H
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1928-1930. PubMed ID: 38303255
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Ginsenoside Rg5 induces NSCLC cell apoptosis and autophagy through PI3K/Akt/mTOR signaling pathway.
    Zhang C; Jin Y
    Hum Exp Toxicol; 2024; 43():9603271241229140. PubMed ID: 38289222
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Spatial and temporal heterogeneity of tumor immune microenvironment between primary tumor and brain metastases in NSCLC.
    Liu JS; Cai YX; He YZ; Xu J; Tian SF; Li ZQ
    BMC Cancer; 2024 Jan; 24(1):123. PubMed ID: 38267913
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Therapy-induced senescent cancer cells exhibit complement activation and increased complement regulatory protein expression.
    Abu-Humaidan AH; Ismail MA; Ahmad FM; Al Shboul S; Barham R; Tadros JS; Alhesa A; El-Sadoni M; Alotaibi MR; Ababneh NA; Saleh T
    Immunol Cell Biol; 2024 Apr; 102(4):240-255. PubMed ID: 38265162
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Josephin domain containing 2 (JOSD2) promotes lung cancer by inhibiting LKB1 (Liver kinase B1) activity.
    Yuan T; Zeng C; Liu J; Zhao C; Ge F; Li Y; Qian M; Du J; Wang W; Li Y; Liu Y; Dai X; Zhou J; Chen X; Ma S; Zhu H; He Q; Yang B
    Signal Transduct Target Ther; 2024 Jan; 9(1):11. PubMed ID: 38177135
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. HER2 and HLA-A*02 dual CAR-T cells utilize LOH in a NOT logic gate to address on-target off-tumor toxicity.
    Bassan D; Weinberger L; Yi J; Kim T; Weist MR; Adams GB; Foord O; Chaim N; Tabak S; Bujanover N; Lopesco Y; Vucci K; Schnair C; Levy-Knafo L; Kendall RL; Calzone FJ; Sharbi-Yunger A
    J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38097342
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. ZYZ384 suppresses the growth of EGFR-mutant non-small cell lung cancer by activating JNK/MAPK signaling pathway.
    Nie XW; Nasim AA; Yao XJ; Fan XX
    Chem Biol Drug Des; 2024 Jan; 103(1):e14408. PubMed ID: 38009559
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Research Progress of BRAF Fusion in Non-small Cell lung cancer].
    Xiao P; Zhong D
    Zhongguo Fei Ai Za Zhi; 2023 Oct; 26(10):782-788. PubMed ID: 37989341
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Rare primary pulmonary mucosa-associated lymphoid tissue lymphoma misdiagnosed with tuberculosis: A case report.
    Gu M; Ji D; Lu Y; Ping G; Yan C
    Medicine (Baltimore); 2023 Nov; 102(46):e36125. PubMed ID: 37986314
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 24.